Global Infectious Vaccines Partnering Terms and Agreements 2010 to 2016: Deal trends, players and financials

Published: October 2016
No. of Pages: 457
    ReportsandReports

"Delivery of this report will take 1-3 days after purchase."

The Global Infectious Vaccines Partnering Terms and Agreements 2010 to 2016: Deal trends, players and financials report provides a detailed understanding and analysis of how and why companies enter infectious vaccines partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors vaccine technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. The report also includes adjuvant deals and alliances.

This report provides details of the latest infectious vaccines agreements announced in the healthcare sectors.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of all infectious vaccines partnering deals announced since January 2010, including financial terms where available, including over 600 links to online deal records of actual infectious vaccines partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of Infectious Vaccines dealmaking and business activities.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in Infectious Vaccines dealmaking since 2010, including details of average headline, upfront, milestone and royalty terms. Infectious Vaccines deals since 2010. Deals are listed by headline value, signed by big pharma, most active Infectious Vaccines dealmaking companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 3 provides a review of the leading Infectious Vaccines deals since 2010. Deals are listed by headline value, signed by big pharma, most active Infectious Vaccines dealmaking companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in Infectious Vaccines dealmaking with a brief summary followed by a comprehensive listing of Infectious Vaccines deals, as well as contract documents available in the public domain. Where available, each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.

Chapter 5 provides a comprehensive and detailed review of Infectious Vaccines partnering deals signed and announced since Jan to 2010, where a contract document is available in the public domain. The chapter is organized by company A-Z, deal type (collaborative R&D, co-promotion, licensing etc), and specific therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive and detailed review of Infectious Vaccines partnering deals signed and announced since Jan to 2010. The chapter is organized by specific Infectious Vaccines technology type in focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided organized by Infectious Vaccines partnering company A-Z, deal type definitions and Infectious Vaccines partnering agreements example. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand. The report also includes numerous tables and figures that illustrate the trends and activities in Infectious Vaccines partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Infectious Vaccines technologies and products.

Report scope

Global Infectious Vaccines Partnering Terms and Agreements 2010 to 2016: Deal trends, players and financials is intended to provide the reader with an in-depth understanding and access to infectious vaccines trends and structure of deals entered into by leading companies worldwide.Global Infectious Vaccines Partnering Terms and Agreements 2010 to 2016: Deal trends, players and financials includes:

Trends in infectious vaccines dealmaking in the biopharma industry since 2010
Analysis of infectious vaccines deal structure
Access to headline, upfront, milestone and royalty data
Access to over 600 infectious vaccines deal records
Identify the most active infectious vaccine dealmakers since 2010
The leading infectious vaccines deals by value since 2010
Includes adjuvant deals and alliances since 2010

In Global Infectious Vaccines Partnering Terms and Agreements 2010 to 2016: Deal trends, players and financials, the available deals are listed by:

Company A-Z
Headline value
Stage of development at signing
Deal component type
Specific infectious therapy target

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Infectious Vaccines Partnering Terms and Agreements 2010 to 2016: Deal trends, players and financials report provides comprehensive access to available deals and contract documents for over 500 infectious vaccines deals. Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?
What is actually granted by the agreement to the partner company?
What exclusivity is granted?
What is the payment structure for the deal?
How aresalesand payments audited?
What is the deal term?
How are the key terms of the agreement defined?
How are IPRs handled and owned?
Who is responsible for commercialization?
Who is responsible for development, supply, and manufacture?
How is confidentiality and publication managed?
How are disputes to be resolved?
Under what conditions can the deal be terminated?
What happens when there is a change of ownership?
What sublicensing and subcontracting provisions have been agreed?
Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
Which jurisdiction does the company insist upon for agreement law?

Infectious Vaccines Partnering Terms and Agreements provides the reader with the following key benefits:

In-depth understanding of infectious vaccines deal trends since 2010
Access infectious vaccines deal headline, upfront, milestone and royalty data
Analysis of the structure of infectious vaccines agreements with numerous real life case studies
Comprehensive access to over 600 links to actual infectious vaccines deals entered into by the world’s biopharma companies, together with real world clause examples
Identify leading infectious vaccines deals by value since 2010
Identify the most active infectious vaccines dealmakers since 2010
Insight into the terms included in infectious vaccines agreement, together with real world clause examples
Understand the key deal terms companies have agreed in previous deals
Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Published By: Current Partnering
Product Code: Current Partnering533


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Related Reports:

  • China Testosterone Propionate Market Research Report 2017

    Notes: Sales, means the sales volume of Testosterone Propionate Revenue, means the sales value of Testosterone Propionate This report studies Testosterone Propionate in China market, focuses on the top players in China market, with capacity, pro...

  • China Dystonia Drug Market Research Report 2017

    Notes: Sales, means the sales volume of Dystonia Drug Revenue, means the sales value of Dystonia Drug This report studies Dystonia Drug in China market, focuses on the top players in China market, with capacity, production, price, revenue and ma...

  • China DHA Soft Capsule Market Research Report 2017

    Notes: Sales, means the sales volume of DHA Soft Capsule Revenue, means the sales value of DHA Soft Capsule This report studies DHA Soft Capsule in China market, focuses on the top players in China market, with capacity, production, price, reven...

  • China DHA Algae Oil Market Research Report 2017

    Notes: Sales, means the sales volume of DHA Algae Oil Revenue, means the sales value of DHA Algae Oil This report studies DHA Algae Oil in China market, focuses on the top players in China market, with capacity, production, price, revenue and ma...

  • China Dermatology Drug Market Research Report 2017

    Notes: Sales, means the sales volume of Dermatology Drug Revenue, means the sales value of Dermatology Drug This report studies Dermatology Drug in China market, focuses on the top players in China market, with capacity, production, price, reven...

  • China Ceramide Market Research Report 2017

    Notes: Sales, means the sales volume of Ceramide Revenue, means the sales value of Ceramide This report studies Ceramide in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for ...

  • China Amlodipine Besylater Market Research Report 2017

    Notes: Sales, means the sales volume of Amlodipine Besylater Revenue, means the sales value of Amlodipine Besylater This report studies Amlodipine Besylater in China market, focuses on the top players in China market, with capacity, production, ...

  • Europe Monoclonal Antibody Market Report 2017

    Notes: Sales, means the sales volume of Monoclonal Antibody Revenue, means the sales value of Monoclonal Antibody This report studies sales (consumption) of Monoclonal Antibody in Europe market, especially in Germany, France, UK, Russia, Italy, ...

  • United States Veterinary/Animal Vaccines Market Report 2017

    Notes: Sales, means the sales volume of Veterinary Animal Vaccines Revenue, means the sales value of Veterinary Animal Vaccines This report studies sales (consumption) of Veterinary Animal Vaccines in United States market, focuses on the top pla...

  • United States Eubiotics Market Report 2017

    Notes: Sales, means the sales volume of Eubiotics Revenue, means the sales value of Eubiotics This report studies sales (consumption) of Eubiotics in United States market, focuses on the top players, with sales, price, revenue and market share f...


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Consumer Goods market as per your needs. Get the best of Consumer Goods research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: